COMPANY FILINGS

Standex

SXI

For fiscal 2026, ended June 30, Standex International Corporation was a diversified industrial manufacturer with four segments: Electronics, Aerospace & Defense, Scientific, and Engraving & Hydraulics.

Business description: FY2026CIK 0000310354Source: SEC EDGAR
Annual reports
5
Report coverage
2022–2026
Financial statement focus
Balance sheet
READ THE FILING

Annual report insights

AI summary

AI-generated summaries of the cited 10-K filings. For informational purposes only; not personalized investment advice.

Choose a fiscal year

Fiscal 2026

Year ended Filed

Read FY2026 annual report (opens in a new tab)
  • Fiscal 2026 net sales increased by US$101.5 million, or 12.8%, from the prior year. Acquisitions contributed US$66.4 million and organic sales growth US$43.6 million, or 5.5%. These are selected contributors, rather than the whole change: exchange rates and business sales also affected the total. Organic growth separates the existing-business change from acquisition, divestiture and exchange-rate effects; Standex includes sales from synergies between acquisitions and existing operations in organic growth.

    Source: 2026
  • Standex recorded a US$57.1 million gain from selling Federal Industries in fiscal 2026. Although the business was sold, its results and the sale gain remained within the continuing-operations accounting category rather than being separately reported as discontinued operations. This classification does not mean Standex retained ownership, and the gain differs from sale proceeds.

    Source: 2026
View full 10-K summary 2026Hide full 10-K summary 2026

Signals describe observations in the selected filing, not forecasts or investment ratings. Risk disclosures do not establish that a loss occurred.

Positive signals

  • Operating cash

    Cash provided by continuing operating activities was $89.9 million for the year ended June 30, 2026, compared with $69.6 million in the prior year.

    Source: 2026

Negative signals

  • Restructuring

    Standex incurred $12.2 million of restructuring expenses in fiscal 2026, primarily for reorganizing facility operations and the announced closure of four Engraving & Hydraulics sites, as well as Electronics restructuring. The announced closures should not be read as confirmation that all four sites had closed.

    Source: 2026
  • Tariff exposure

    Standex disclosed that many components and finished goods it imports from China and India are or have been subject to U.S. tariffs. As a conditional risk, it warned that competition could limit its ability to sustain price increases to recover these costs, adversely affecting sales, profits and cash flows.

    Source: 2026

Business context

  • Narayan ownership

    On June 26, 2026, Standex agreed to acquire the remaining 9.90% of Narayan for approximately $64.0 million in cash. The transaction closed on July 2, 2026, after the fiscal year-end; the purchase was therefore not completed within fiscal 2026.

    Source: 2026

Business in fiscal 2026

For fiscal 2026, ended June 30, Standex International Corporation was a diversified industrial manufacturer with four segments: Electronics, Aerospace & Defense, Scientific, and Engraving & Hydraulics.

Source: 2026

5-year changes

FY2022–FY2026

These changes use selected original filing passages and nearby context from the stated five fiscal years. They are not an exhaustive review of all five reports and exclude later-year filings.

  • Borrowings

    Standex's outstanding borrowings under its credit facility, a borrowing arrangement with lenders, were $175.0 million at June 30, 2022, $150.0 million at June 30, 2024, and $518.2 million at June 30, 2026. Separately, its fiscal 2025 report disclosed an expansion of total available credit from $500 million to $825 million. That facility limit is distinct from the amount actually borrowed.

    Source: 2022, 2024, 2025, 2026
  • Scientific demand

    Management linked Scientific's fiscal 2022 sales growth partly to strong demand for cold storage used in COVID-19 vaccine distribution. In fiscal 2023, it attributed the segment's sales decline to lower vaccine-storage demand, partly offset by pricing. In fiscal 2025, management attributed sales growth to the Custom Biogenic Systems acquisition, mostly offset by lower demand at academic and research institutions affected by National Institutes of Health funding cuts.

    Source: 2022, 2023, 2025
  • Business structure

    Standex reported five reportable segments in fiscal 2025, compared with four in fiscal 2026. After selling Federal Industries in fiscal 2026, it combined Hydraulics with Engraving and renamed Engineering Technologies as Aerospace & Defense. The fiscal 2026 report revised its presented comparison periods to the new segment structure, so its Engraving & Hydraulics figures should not be treated as the same business scope as earlier standalone Engraving figures.

    Source: 2025, 2026
Request a correction

This request covers the entire SXI FY2026 summary, including the 5-year comparison.

We keep your message and the summary version as a record of our review and any correction. Personal information included in a message is removed during review. Please do not include personal details, passwords or private URLs. Your message is not published. Requests are stored privately with our database provider. Hosting and security providers may process technical data such as IP addresses. Removal applies to the application record; provider backups and security logs follow their retention rules.

FINANCIAL STATEMENTS

Balance sheet

A snapshot of what Standex owns and owes at a point in time.

The original comes first.

Read the company’s balance sheet in the original annual reports below.

Browse original filings
Assets
What the company owns
Liabilities
What the company owes
Equity
Assets less liabilities

See the original statement for its reporting period, currency, and unit.

SOURCE LIBRARY

Annual reports & SEC 10-K filings

SEC EDGAR

5 reports in this collection

Original SEC annual reports, with report period and filing date
Report periodFiled with SECFormSource
Jun 30, 20260001437749-26-027789Aug 14, 202610-KOpen 10-Ksec.govRead FY2026 summary
Jun 30, 20250001437749-25-024450Aug 4, 202510-KOpen 10-Ksec.gov
Jun 30, 20240001437749-24-024465Aug 2, 202410-KOpen 10-Ksec.gov
Jun 30, 20230001437749-23-022156Aug 4, 202310-KOpen 10-Ksec.gov
Jun 30, 20220001437749-22-019128Aug 5, 202210-KOpen 10-Ksec.gov

Dates describe the filing metadata. Figures and reporting periods should be checked against the original statement. SEC links open in a new tab.